kt nasmedia Co., Ltd. Logo

kt nasmedia Co., Ltd.

An integrated digital marketing platform for data-driven online, mobile, and OOH ad solutions.

089600 | KO

Overview

Corporate Details

ISIN(s):
KR7089600001
LEI:
Country:
South Korea
Address:
서울특별시 강남구 도곡로1길 14 삼일프라자오피스텔4,5F, 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

kt nasmedia Co., Ltd. is a digital marketing platform company that provides integrated media planning and advertising solutions. The company specializes in online, mobile, digital broadcasting, and digital out-of-home (OOH) advertising. Leveraging a deep understanding of ad-tech, the firm offers data-driven audience planning and campaign optimization services. It aims to develop innovative digital advertising platforms based on big data and artificial intelligence to deliver optimal marketing outcomes for its clients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Regulatory News Service
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 5.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-13 00:00
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.0 KB
2025-08-07 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 15.6 KB
2025-07-25 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 1.3 MB
2025-05-30 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 107.9 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.2 MB
2025-05-13 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.9 KB
2025-05-13 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.6 KB
2025-04-28 00:00
Capital/Financing Update
[기재정정]주권관련사채권의취득결정
Korean 38.0 KB
2025-04-14 00:00
Notice of Dividend Amount
[기재정정]현금ㆍ현물배당결정
Korean 11.7 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 31.7 KB
2025-03-28 00:00
Post-Annual General Meeting Information
상호변경안내
Korean 5.9 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 9.9 KB
2025-03-20 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 499.6 KB

Automate Your Workflow. Get a real-time feed of all kt nasmedia Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for kt nasmedia Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for kt nasmedia Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan
9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan
9227
MindWalk Holdings Corp. Logo
AI-powered biotherapeutics firm offering end-to-end antibody discovery and engineering services.
United States of America
HYFT
Minerva Neurosciences, Inc. Logo
A clinical-stage biopharma developing treatments for central nervous system (CNS) diseases.
United States of America
NERV
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan
3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea
417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden
MODTX
Moleculin Biotech, Inc. Logo
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland
MOC

Talk to a Data Expert

Have a question? We'll get back to you promptly.